BSEBoard Meeting6d ago · 4 Nov 2026, 04:48 pm
KMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday, November 14, 2026 at 1:00 pm at the registered office of the Company ....
KMS Medisurgi Ltd · 540468
✦ AI SummaryResults
KMS Medisurgi Ltd has scheduled a Board Meeting on November 14, 2026, to consider and approve the Un-Audited Financial Results for the half year ended September 30, 2026, and other items.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
KMS Medisurgi Ltd - 540468 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday, November 14, 2026
Attachments (1)
📄pdf
Download →
4ae8053a-e3f6-4948-8847-26b6b0607051.pdf
View document text
KMS MEDISURGI LIMITED
® Plot No-297/301 May Building, Gr. Floor Marine lines (EAST), Princess Street,
Mumbai 400 002 Maharashtra (India)
o CIN: L51397MH1999PLC119118
Website: www.kmsgroup.in | E-mail Id: cskms99@gmail,com
Tel: 022-66107700/22, 022-67498822 | Fax: +91-22-22061111
Date: 04.11.2026
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai-400001
Subject: Intimation of Board Meeting to be held on Saturday, November 14, 2026.
Ref: KMS Medisurgi limited (scrip code- 540468)
Dear Sir/Madam,
This is to inform you that Pursuant to Regulation 29 and 33 of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015, we wish to inform you that the meeting of
the Board of Directors of the Company is scheduled to be held on Saturday, November 14,
2026 at 1:00 pm at the registered office of the Company to consider and approve:
1. The Un-Audited Financial Results of the Company for the half year ended 30th
September, 2026 and the Limited review report thereon;
2. Any other items, if any.
Further, in terms of Company's "Code of Conduct for Prevention of Insider Trading", the
closure of trading window for purchase/sale of securities of the Company by the Designated
persons and theirimmediate relatives has already commenced from October 1, 2026 and will
end Forty-Eight (48) hours after the declaration of Financial Results of the Company for the
Half year ended on 30th September, 2026.
You are requested to take the above mentioned information on your records.
Yours faithfully,
For KMS Medisurgi Limited
FOR KMS MEDISURGI LIMITED
Siddharth Kanakia
Managing Director
DIN: 07595098
Place: Mumbai